Sabrina Lesage, PhD, is Business Development & Strategic Alliances Lead at Pfizer France. With over a decade in Global Clinical Development and successful drug registrations (FDA & EMA), she now focuses on open innovation and external partnerships. She leads startup acceleration programs, scouts for innovative digital solutions, and represents Pfizer in key national health innovation bodies such as LEEM and ARIIS. She also engages with French VCs and is a member of the Tibi II fund selection committee.
Pfizer is a global biopharmaceutical company dedicated to discovering and delivering innovative medicines and vaccines that improve lives. Founded in 1849 and headquartered in New York City, Pfizer employs over 80,000 people worldwide. The company focuses on key therapeutic areas such as oncology, immuno-inflammation, vaccines, and cardiovascular and metabolic diseases. With a strong commitment to quality, safety, and access, Pfizer works closely with healthcare providers, governments, and communities around the world to advance health solutions and make a lasting impact.
